Reversible left ventricular obstruction after treatment of pheochromocytoma and hyperthyroidism;Obstruction intraventriculaire gauche reversible apres traitement d'un pheochromocytome et d'une hyperthyroidie

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue 12, 1998, Pages 1513-1518

  Gandolfini, M P ^a   Lefrancois A M ^b   Pannier Moreau, I ^c   Guiomard, A ^a  

^a Hopital Max Fourestier   (France)

^b SAINT JOSEPH HOSPITAL   (France)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALECTOMY; ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE REGULATION; CARDIOMYOPATHY; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPERTHYROIDISM; PHEOCHROMOCYTOMA; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; TREATMENT OUTCOME; ADRENAL TUMOR; HEART OUTFLOW TRACT OBSTRUCTION; MULTIMODALITY CANCER THERAPY;

ANTITHYROID AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADRENAL GLAND NEOPLASMS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTITHYROID AGENTS; ATENOLOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHYROIDISM; PHEOCHROMOCYTOMA; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 0032412014     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. e édition. Paris : Flammarion Médecine Sciences, 1996: 1798-9.
2. Radien P, Jeunemaitre X, Dumont C, Beldjord C, Plouin PF. Genetic alterations of the RET proto oncogene in familial and sporadic pheochromocytomas. Horm Res 1997; 47: 263-8.
3. Braverman LE, Sullivan RM. Another polyendocrine disorder: pheochromocytoma and diffuse toxic goiter. Hopkins Med J 1969; 125: 331-5.
4. Gutierrez Millet V, Izquierdo Pablos J, Alonso Barbolla J, Garcia Lozano ML. Feocromocitoma y bocio multinodular toxico: asociacion infrecuente. Med Clin 1990; 95 (14): 559.
5. Sardesai SH, Mourant AJ, Sivathandon Y, Farrow R, Gibbons DO. Pheochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J 1990; 63: 234-7.
6. Plouin PF, Azizi M, Day M, Duclos JM, Corvol P. The pathophysiological basis of current pheochromocytoma management. In : Pinsky MR, Dhainaut JFA (eds). Pathophysiologic foundations of critical care. Baltimore : Williams and Wilkins, 1992: 917-24.
7. Denolle T, Julien J, Chatellier G, Battaglia C. Retentissement ventriculaire gauche dans l'adénome de Conn, l'hypertension rénovasculaire et le phéochromocytome avant et après traitement étiologique. Arch Mal Cæur 1992 ; 85 : 1131-5
8. Huddle KR, Kalliatakis B, Skoularigis J. Pheochromocytoma associated with clinical and ecnocardiographic features simulating hypertrophic obstructive cardiomyopathy. Chest 1996 ; 109: 1394-7.
9. Jacob JL, Da Silvera LC, De Freitas CG, Pereira Centola CA, Nicolau JC, Lorga AM. Pheochromocytoma with echocardiographic features of obstructive hypertrophic cardiomyopathy. A case report. Angiology 1994 ; 45 : 985-9.
10. Bravo E, Fouad-Tarazi F, Rossi G et al. A reevaluation of the hemodynamics of pheochromocytoma. Hypertension 1990 ; 15(suppl 1): I-128-I-131.